Showing results (191-200 of 268) with videos related to
Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Phase II clinical trial of triazinate in combination with mitomycin C for patients with advanced gastric cancerM J O'Connell, A J Schutt, C G Moertel, et al.Cancer Research|November 11, 1975
Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancerC G Moertel, R E Ritts, A J Schutt, et al.Acta Anaesthesiologica Scandinavica|April 1, 1993
Haemodynamics and fluid balance after intravenous infusion of 1.5% glycine in sheepH P Stalberg, R G Hahn, H Hjelmqvist, et al.Journal of the National Cancer Institute|January 1, 1975
Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristineC G Moertel, A J Schutt, R G Hahn, et al.Clinical Pharmacology and Therapeutics|November 1, 1975
Oral benzquinamide in the treatment of nausea and vomitingC G Moertel, A J Schutt, R G Hahn, et al.Cancer|April 1, 1975
A double-blind comparison of intensive course 5-flourouracil by oral vs. intravenous route in the treatment of colorectal carcinomaR G Hahn, C G Moertel, A J Schutt, et al.Journal of the National Cancer Institute|January 1, 1976
Phase I study of a five-day intermittent schedule for 1,2:5,6-dianhydrogalactitol (NSC-132313)R T Eagan, C G Moertel, R G Hahn, et al.The Journal of Family Practice|February 1, 1992
Obstetric ultrasound by family physiciansW M Rodney, M E Deutchman, K J Hartman, et al.Cancer Chemotherapy Reports|June 1, 1972
Evaluation of cyclophosphamide (NSC-26271) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of patients with inoperable or disseminated lung cancerD L Ahmann, D T Carr, D T Coles, et al.Cancer Treatment Reports|September 1, 1979
Chemotherapy for advanced germinal cell neoplasms: preliminary report of an Eastern Cooperative Oncology Group StudyW D DeWys, C Begg, R Slayton, et al.Pageof 27